Revenue | ₹5.40Cr |
Net Profits | ₹0.05Cr |
Net Profit Margins | 0.93% |
Beryl Drugs Ltd’s revenue fell -29.5% since last year same period to ₹5.40Cr in the Q3 2024-2025. On a quarterly growth basis, Beryl Drugs Ltd has generated -4.42% fall in its revenue since last 3-months.
Beryl Drugs Ltd’s net profit fell -83.87% since last year same period to ₹0.05Cr in the Q3 2024-2025. On a quarterly growth basis, Beryl Drugs Ltd has generated 400% jump in its net profits since last 3-months.
Beryl Drugs Ltd’s net profit margin fell -77.12% since last year same period to 0.93% in the Q3 2024-2025. On a quarterly growth basis, Beryl Drugs Ltd has generated 423.15% jump in its net profit margins since last 3-months.
The revenue for Beryl Drugs Ltd in the Q3 results 2024 was ₹5.40Cr.
The net profit for Beryl Drugs Ltd in the Q3 results 2024 was ₹0.05Cr.
The net profit margin for Beryl Drugs Ltd in the Q3 results 2024 was 0.93%.
The revenue for Beryl Drugs Ltd in the Q3 results 2023 was ₹7.66Cr.
The net profit for Beryl Drugs Ltd in the Q3 results 2023 was ₹0.31Cr.
The net profit margin for Beryl Drugs Ltd in the Q3 results 2023 was 4.05%.